Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2009
12/30/2009WO2009124353A8 Modified cpn10 and prr signalling
12/30/2009WO2009120837A3 Leucine-rich peptide compositions and methods for isolation
12/30/2009WO2009120549A3 Methods to increase permeability of corneal epithelium and destabilize stromal collagen fibril network
12/30/2009WO2009120378A3 Methods for increasing absorption of peptides, peptidomimetics, and other gastrointestinal transport protein substrates
12/30/2009WO2009114197A3 Reactivation of axon growth and recovery in chronic spinal cord injury
12/30/2009WO2009111543A3 Treatment of hearing and balance impairments with redox-active therapeutics
12/30/2009WO2009111471A3 Collagen-derived peptide as biomarker, therapeutic agent and target
12/30/2009WO2009108695A3 Methods for prevention and treatment of acute renal injury
12/30/2009WO2009108347A3 Antibacterial peptides active in systemic infections
12/30/2009WO2009108340A3 Leptin agonist and methods of use
12/30/2009WO2009105217A3 Complement inhibitors as therapeutic agents for treatment of cancer
12/30/2009WO2009100363A3 Methods for preventing or treating insulin resistance
12/30/2009WO2009099998A3 Therapeutic treatment for lung conditions
12/30/2009WO2009097530A3 Peptides that target dorsal root ganglion neurons
12/30/2009WO2009079451A3 Compositions and methods of promoting wound healing
12/30/2009WO2009078977A9 Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxins
12/30/2009WO2009070753A3 Bivalent single chain fv antibody compositions that specifically bind to integrin receptor on a metastatic cell in a mammalian subject
12/30/2009WO2009067245A3 Compositions and methods for tissue repair
12/30/2009WO2009067177A3 Bone morphogenic protein binding peptide
12/30/2009WO2009059225A3 Analgesia with minimal tolerance and dependence by a mu opioid receptor agonist that also binds filamin a
12/30/2009WO2009059143A3 Use of toll-like receptor 4 antagonists for the treatment or prevention of osteoarthritic conditions
12/30/2009WO2009059011A9 Hla-dr binding peptides and their uses
12/30/2009WO2009054967A3 Compositions for delivery of glycopeptide antibiotics
12/30/2009WO2009053828A3 P3 hydroxyamino macrocyclic hepatitis c serine protease inhibitors
12/30/2009WO2009038729A3 Compositions and methods utilizing fibrin beta chain fragments of the bbeta chain of fibrinogen
12/30/2009WO2009032943A3 Methods and compositions for delivery of growth factor to fibrous connective tissue
12/30/2009WO2009032148A8 Methods of making and using a cell penetrating peptide for enhanced delivery of nucleic acids, proteins, drugs, and adenovirus to tissues and cells, and compositions and kits
12/30/2009WO2009018477A3 Methods of inhibiting calcineurin with apoe analogs
12/30/2009WO2008154151A3 Surfactant usage in lung transplantation and methods thereof
12/30/2009WO2008153788A3 Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof
12/30/2009WO2008144611A3 Il-9 in fibrotic and inflammatory disease
12/30/2009WO2008140335A3 Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
12/30/2009WO2008131215A3 Engineered phosphite dehydrogenase mutants
12/30/2009WO2008119027A3 Genetic testing of telomere-associated genes in dyskeratosis congenita and related disorders
12/30/2009WO2008109794A3 The role of the mk2 pathway in treating fibrosis and scarring
12/30/2009WO2008100727A3 High-dose glycine as a treatment for obsessive-compulsive disorder and obsessive-compulsive spectrum disorders
12/30/2009WO2008091934A3 Fructose 1, 6 bisphosphate - a novel anticonvulsant drug
12/30/2009EP2138580A1 Vector for gene therapy
12/30/2009EP2138575A1 Conjugates comprising a biodegradable polymer and uses therefor
12/30/2009EP2138507A1 Method for producing intermediates for the production of novel macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof, and uses of said macrocycles
12/30/2009EP2138190A2 Compositions comprising dietary fat complexer and methods for their use
12/30/2009EP2138185A1 System for the determination of molecules altering the function of interferon, method therefor and compounds altering interferon activity
12/30/2009EP2138184A1 Prophylactic agent for renal failure
12/30/2009EP2138179A1 Use of cytidine derivatives for the treatment of leukaemia
12/30/2009EP2138170A2 Prevention and Treatment of Oxidative Stress Disorders by compounds which elevate intracellular levels of glutathione or Phase II Detoxification Enzymes
12/30/2009EP2138159A1 Whitening agent
12/30/2009EP2137539A1 Amiloride sensitive sodium channels associated with panic disorders
12/30/2009EP2137531A2 Biased ligands for receptors such as the pth receptor
12/30/2009EP2137213A1 Methods and compositions for treating prostate cancer
12/30/2009EP2137209A1 Compounds for the diagnosis of diseases associated with vcam expression
12/30/2009EP2137204A1 Use of substrates as pharmacological chaperones
12/30/2009EP2136843A1 Biomarkers of prostate cancer and uses thereof
12/30/2009EP2136832A1 Methods for promoting protection and regeneration of bone marrow using cxcl9 and anti-cxcl9 antibodies
12/30/2009EP2136831A2 Anti-angiogenic peptides
12/30/2009EP2136830A2 Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
12/30/2009EP2136620A2 Methods and compositions for targeting afap
12/30/2009EP1689426B1 Pharmaceutical formulations for the sustained release of interferons and therapeutic applications thereof
12/30/2009EP1504037B1 Ferritin fusion proteins for use in vaccines and other applications
12/30/2009EP1470239B1 Psoriasin expression by breast epithelial cells
12/30/2009EP1272663B1 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications
12/30/2009EP0804561B1 Regulated transcription of targeted genes and other biological events
12/30/2009CN101616685A Unstructured recombinant polymers and uses thereof
12/30/2009CN101616684A Modulators of sclerostin binding partners for treating bone-related disorders
12/30/2009CN101616683A Non-immunosuppressive cyclosporin for treatment of Ullrich congenital muscular dystrophy
12/30/2009CN101616682A Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from HIV-TAT
12/30/2009CN101613688A Von willebrand factor (vWF)-cleaving protease
12/30/2009CN101613307A Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
12/30/2009CN101612402A Interferon antagonist and use of Flt3L interferon
12/30/2009CN101612393A Application method for microbic muramidase in medicament and additive for preventing pig disease
12/30/2009CN101612392A Preparation for preventing and curing mammalian endometritis and preparation method thereof
12/30/2009CN101612391A Medicinal composition for treating insomnia
12/30/2009CN101612390A Method for preparing subcutaneously implanted long-acting sustained-release preparation for insulin
12/30/2009CN101612389A Antiviral drug combination for livestock
12/30/2009CN101612388A High-effect pig alpha-interferon injection and preparation method thereof
12/30/2009CN101612387A Application of macrophage regulating protein MIRF in preparing anti-inflammatory medicament
12/30/2009CN101612386A Application of active peptide of deer blood in preparing antihypertensive medicaments and health care products
12/30/2009CN101612385A Application of rLZ-8 in treating thrombopenia and preparation thereof
12/30/2009CN101612384A Application of polypeptide small molecule MLIF in preparing medicine for preventing and treating myocardial ischemia
12/30/2009CN100575492C CDNA sequence of coding perinereis albuhitensis grube protease and amino acid sequence thereof
12/30/2009CN100575482C Novel cytokine zcytor17 ligand
12/30/2009CN100575359C Rana grahami boulenger antibiotic peptide and application thereof
12/30/2009CN100574802C Compound stypticum
12/30/2009CN100574801C Liquid growth hormone formulation
12/30/2009CA2729420A1 Combination of amidine derivates with cyclic depsipeptides
12/30/2009CA2729139A1 Octreotide implant having a release agent
12/30/2009CA2729098A1 Antagonists of activin-actriia and uses for increasing red blood cell levels
12/30/2009CA2729054A1 Antagonists of actriib and uses for increasing red blood cell levels
12/30/2009CA2728933A1 Bridged secondary amines and use thereof as iap bir domain binding compounds
12/30/2009CA2728734A1 Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof
12/30/2009CA2728719A1 Therapeutic proteins from latex
12/30/2009CA2728708A1 Factor viii muteins with reduced immunogenicity
12/30/2009CA2728674A1 Signatures and determinants associated with metastasis methods of use thereof
12/30/2009CA2728363A1 Use of hsp70 as a regulator of enzymatic activity
12/30/2009CA2728142A1 System for the determination of molecules altering the function of interferon, method therefor and compounds altering interferon activity
12/30/2009CA2728012A1 Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life
12/30/2009CA2728000A1 Polysaccharide-protein conjugates reversibly coupled via imine bonds
12/30/2009CA2726894A1 Therapeutic agents comprising elastin-like peptides
12/30/2009CA2726837A1 Lyophilization cycle robustness strategy
12/30/2009CA2726283A1 Stimulation of cartilage formation using reduced pressure treatment
12/29/2009US7638620 Use to enhance apoptosis; antiproliferative agents
1 ... 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 ... 3163